II. Evaluation: Vital Sign Monitoring
-
Vital Signs: Temp, Pulse, Blood Pressure, Respirations
- Start with every 4 hours for 12 hours
- Space to every 6 hours
- Peak Expiratory Flow (PEFR)
-
Oxygen Saturation Monitor
- Oxygen to keep Oxygen Saturation adequate
- Adults: >90%
- Children: >95%
- Discontinuation Criteria
- Oxygen Saturation adequate for 4 hours
- Patient on general ward
- Continue spot check Oxygen Saturation
- Perform with Vital Signs
- As needed for respiratory distress
- Oxygen to keep Oxygen Saturation adequate
- Telemetry monitor (cardiac monitor) Indications
- Albuterol Nebulizer more than every 4 hours
- Infant or young child
- Corroborate Oxygen Saturation monitor (match pulse)
- Child movement makes Oxygen Saturation inaccurate
III. Management: Medications
- See Albuterol Nebulizer dose
-
Corticosteroids
- Methylprednisolone (Solu-medrol)
- Dose: 1 mg/kg/dose q6 hours
- Maximum Dose: 60 mg IV q6 hour OR 80 mg IV q8 hours
- Oral Prednisone
- Indications to switch from Solu-medrol
- Albuterol Nebulizer spaced to 4 hours or more
- Tolerating oral intake (No Nausea or Vomiting)
- Dose
- Prednisone 1-2 mg/kg/day qd-bid
- Maximum: 40-60 mg/day for 5-10 days
- No tapering needed if use less than 2 weeks
- Indications to switch from Solu-medrol
- Methylprednisolone (Solu-medrol)
IV. Evaluation: Monitoring
-
Arterial Blood Gas Indications (on admission)
- Pulmonary Function Test Criteria
- PEFR < 30%
- Prior history of pCO2 > 40
- Failure to improve in 4 hours of therapy
- Clinical Asthma score >7
- Pulmonary Function Test Criteria
- Indications to monitor serum Electrolytes
- Nausea or Vomiting
- Intravenous Fluids for more than 24 hours
- Beta Agonists more than every 4 hours for 24 hours
- Chest XRay Indications
V. Evaluation: Signs of Improvement
- Minimal or no Wheezing
- Less than 2 night awakenings for Mild Asthma symptoms
- Good activity tolerance
- Pulmonary Function Test criteria
- Adequate Oxygen Saturation off Supplemental Oxygen
VI. Management: More Intensive Treatment Options
- Intensive Care unit for no improvement in 6-12 hours
- See Status Asthmaticus
VII. Management: Preparation for Discharge
- Asthma-Related Death Risk Factors
- Inhaled Beta Agonist no more then q4 hours
- Parenteral steroids switched to Oral Corticosteroids
- Adequate Oxygen Saturation on room air
-
Asthma Education: Medication use
- Inhaled Corticosteroid by bedside
- Respiratory Therapy or nurse to instruct use bid
- Peak Flow measurement at home
- Follow-up in clinic in 7-10 days
VIII. References
- (1997) Management of Asthma, NIH 97-4053
- (1995) Global Strategy for Asthma, NIH 95-3659
- Pollart (2011) Am Fam Physician 84(1): 40-7 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
| Concepts | Finding (T033) |
| SnomedCT | 195978009, 367110001, 281239006 |
| Dutch | exacerbatie van astma |
| German | Exazerbation des Asthmas |
| Italian | Esacerbazione di asma |
| Portuguese | Exacerbação de asma |
| Spanish | Exacerbación de asma, exacerbación de asma (trastorno), exacerbación de asma |
| Japanese | 喘息増悪, ｾﾞﾝｿｸｿﾞｳｱｸ |
| French | Exacerbation de l'asthme |
| English | asthma with acute exacerbation, asthma with acute exacerbation (diagnosis), asthma exacerbation, exacerbation of asthma, acute exacerbation of asthma, acute asthma exacerbation, exacerbation asthma, of asthma exacerbation, asthma exacerbations, Exacerbation of asthma, Acute exacerbation of asthma, Exacerbation of asthma (disorder) |
| Czech | Exacerbace astmatu |
| Hungarian | Asthma exacerbatiója |
